出 处:《中国医疗器械信息》2022年第23期144-146,共3页China Medical Device Information
摘 要:目的:探讨临床在实施乳房良性肿瘤诊疗期间乳腺微创旋切术的应用可行性。方法:将2017年6月~2020年5月本院收治的70例乳房良性肿瘤患者按照数字奇偶法分组。观察组(35例):采用乳腺微创旋切术完成疾病诊疗;对照组(35例):采用传统手术方法完成疾病诊疗。对组间皮肤感觉、乳房外形、切口瘢痕治疗效果、术中出血量、手术时间、术后住院时间以及VAS(视觉模拟疼痛)评分、血清CA125(糖链抗原125)水平以及血清CEA(肿瘤标志物癌胚抗原)水平展开对比。结果:观察组乳房良性肿瘤患者皮肤感觉无异常率(97.14%)、乳房外形无变形率(97.14%)以及切口瘢痕不明显率(94.29%)均高于对照组皮肤感觉无异常率(57.14%)、乳房外形无变形率(60.00%)以及切口瘢痕不明显率明显(P<0.05);观察组术中出血量(18.71±4.21)mL、手术时间(35.56±5.41)min、术后住院时间(2.92±0.53)d以及VAS评分(2.83±0.06)分均少于对照组术中出血量(23.36±4.53)mL、手术时间(51.46±5.66)min、术后住院时间(3.41±0.63)d以及VAS评分(5.31±0.07)分(P<0.05);手术前,观察组乳房良性肿瘤患者血清CA125水平以及血清CEA水平同对照组比较,差异不明显(P>0.05);手术后,观察组乳房良性肿瘤患者血清CA125水平以及血清CEA水平同对照组比较,差异不明显(P>0.05)。结论:乳腺微创旋切术的有效运用,可使乳房良性肿瘤患者皮肤感觉、乳房外形以及切口瘢痕获得显著改善,将术中出血量减少,将手术时间以及术后住院时间缩短,将疼痛程度降低,最终实现乳房良性肿瘤患者有效预后。Objective:To investigate the feasibility of minimally invasive breast surgery during the diagnosis and treatment of benign breast tumors.Methods:A total of 70 patients with benign breast tumors admitted to our hospital from June 2017 to May 2020 were grouped according to the numerical parity method.Minimally invasive group(35 cases):minimally invasive breast gyrotomy was performed to complete disease diagnosis and treatment;Conventional group(35 cases):traditional surgical methods were used to complete disease diagnosis and treatment;The skin sensation,breast shape,incision scar treatment effect,intraoperative bleeding,operation time,postoperative hospital stay,VAS(visual analog pain)score,serum CA125(carbohydrate antigen 125)level and serum CEA(tumor marker carcinoembryonic antigen)level were compared among groups.Results:The rates of no abnormal skin sensation(97.14%),no breast contour deformity(97.14%)and no obvious incision scar(94.29%)in the minimally invasive group were significantly higher than those in the conventional group(57.14%),no breast contour deformity(60.00%)and no obvious incision scar(P<0.05);The intraoperative blood loss(18.71±4.21)mL,operative time(35.56±5.41)min,postoperative hospital stay(2.92±0.53)d and VAS score(2.83±0.06)points in minimally invasive group were all lower than those in conventional group(23.36±4.53)mL and operative time(51.46±5.66)min,postoperative hospital stay(3.41±0.63)d and VAS score(5.31±0.07)(P<0.05);Before surgery,there was no significant difference in serum CA125 level and serum CEA level between minimally invasive group and conventional group(P>0.05).After surgery,there was no significant difference in serum CA125 level and serum CEA level between the minimally invasive group and the conventional group(P>0.05).Conclusion:The effective application of minimally invasive breast tomy can significantly improve the skin sensation,breast shape and incision scar of patients with benign breast tumor,reduce intraoperative blood loss,shorten the operation time and po
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...